Riddhi Siddhi Gluco Biols' Q1 FY 2026-27 Quarterly Results
- 14 Aug 2026
Result Summary
- Riddhi Siddhi Gluco Biols Ltd reported a 432.7% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Jun (Q1 FY 2026-27). On a year-on-year (YoY) basis, it witnessed a decline of 39.2%.
- Its expenses for the quarter were up by 327.5% QoQ and down 37.1% YoY.
- The net profit decreased 109.2% QoQ and decreased 62.6% YoY.
- The earnings per share (EPS) of Riddhi Siddhi Gluco Biols Ltd stood at 4.21 during Q1 FY 2026-27.
Financial Statments for Q1 FY 2026-27
(₹ crores) | Q1FY27 | Q4FY26 | Q1FY26 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 106.86 | 20.06 | 175.78 | 432.7% | -39.2% |
Total Expenses | 101.05 | 23.64 | 160.66 | 327.5% | -37.1% |
Profit Before Tax | 5.82 | -3.58 | 15.13 | -262.6% | -61.5% |
Tax | 1.98 | 1.37 | 5.53 | 44.5% | -64.2% |
Profit After Tax | 3.01 | -32.73 | 8.04 | -109.2% | -62.6% |
Earnings Per Share | 4.21 | -45.92 | 11.27 | -109.2% | -62.6% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Riddhi Siddhi Gluco Biols Ltd is a company operating within the starch and starch derivatives industry. It primarily focuses on the production and distribution of various starch-based products. The company has established itself as a significant player in the market by catering to diverse industries such as food processing, paper, textiles, and pharmaceuticals, which utilize starch and its derivatives extensively. While specific recent developments are not available, companies in this sector often engage in activities related to capacity expansion, technological advancements, and the exploration of new markets to enhance their competitive position.
Revenue
In Q1FY27, Riddhi Siddhi Gluco Biols Ltd reported a total income of ₹106.86 crores. This represented a substantial increase of 432.7% when compared to ₹20.06 crores recorded in Q4FY26. However, on a year-over-year basis, there was a notable decline of 39.2% from the ₹175.78 crores reported in Q1FY26. The quarter-over-quarter growth signifies a significant recovery in revenue, but the year-over-year decline indicates a deviation from past performance levels.
Profitability
The company's profitability metrics for Q1FY27 reveal a mixed performance. The Profit Before Tax (PBT) stood at ₹5.82 crores, marking a turnaround from the negative PBT of ₹-3.58 crores in Q4FY26, reflecting a quarter-over-quarter improvement of 262.6%. However, when compared to Q1FY26, the PBT decreased by 61.5% from ₹15.13 crores. The Profit After Tax (PAT) for Q1FY27 was ₹3.01 crores, compared to a loss of ₹-32.73 crores in Q4FY26, translating to a 109.2% improvement quarter-over-quarter. Year-over-year, PAT decreased by 62.6% from ₹8.04 crores. Earnings Per Share followed a similar trend, increasing quarter-over-quarter from a negative figure to ₹4.21, but decreasing year-over-year from ₹11.27.
Operating Metrics
The total expenses for Riddhi Siddhi Gluco Biols Ltd in Q1FY27 were ₹101.05 crores, which increased by 327.5% from ₹23.64 crores in Q4FY26. Compared to Q1FY26, there was a decrease of 37.1% from ₹160.66 crores. Tax expenses for the quarter were ₹1.98 crores, representing a 44.5% increase from ₹1.37 crores in the previous quarter, while showing a year-over-year decrease of 64.2% from ₹5.53 crores. The financial data reflects substantial fluctuations in operating metrics, highlighting changes in the cost structure and tax obligations over the periods in question.
FAQs
Riddhi Siddhi Gluco Biols Ltd announced its Q1 FY 2026-27 results on 14 August, 2026.
Riddhi Siddhi Gluco Biols Ltd quarterly results refer to the company’s financial performance over a three-month period, including key metrics like revenue, net profit, earnings per share (EPS), and margin performance.
Key highlights of Riddhi Siddhi Gluco Biols Ltd Q1 FY 2026-27 results include:
- Revenue: ₹106.86 crore
- Net Profit: ₹3.01 crore
- EBITDA: ₹13.51 crore
- Year-over-Year Growth: -39.2%
- Quarter-over-Quarter Growth: 432.7%
Riddhi Siddhi Gluco Biols Ltd reported a net loss of ₹3.01 crore in Q1 FY 2026-27, reflecting a -62.6% year-over-year growth.
Riddhi Siddhi Gluco Biols Ltd posted a revenue of ₹106.86 crore in Q1 FY 2026-27.